NEWPORT BEACH, Calif. - August 2, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Sunshine Biopharma (OTC: SBFM) after releasing the latest short sale data through July 31, 2012. The total aggregate number of shares shorted since January 2010 is approximately 3.97 million shares. Approximately 40.11% of daily trading volume is short selling. The SqueezeTrigger price for all SBFM shares shorted is $0.47. A short squeeze is expected to begin when SBFM closes above its $0.47 SqueezeTrigger Price.